In interviews with Ars Technica this week, OpenAI employees revealed the extent to which the company now relies on its own AI ...
Oncolytics Biotech Inc. (NASDAQ: ONCY) has secured FDA alignment on its pivotal Phase 3 study design for pelareorep in first-line metastatic pancreatic cancer, positioning the company to launch the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback